Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Johnson & Johnson (JNJ)  
$146.14 0.68 (0.46%) as of 4:30 Fri 4/26


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 2,630,000,000
Market Cap: 384.35(B)
Last Volume: 6,182,604 Avg Vol: 8,314,942
52 Week Range: $144.45 - $174.48
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     DOW JONES COMPOSITE
    DOW JONES INDUSTRIAL AVERAGE     NYSE COMPOSITE
    S&P 100     S&P 500
    MAJOR MARKET

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  21
Guru Rank Value     : 20.3
Guru Occurances    : 6

 

            6 Months   1 Year   2 Year  
 
Company Profile   Johnson & Johnson is a holding company. Through its subsidiaries, Co. is engaged in the research and development, manufacture and sale of products in the health care field. Co. has three business segments: Consumer Health, which includes products focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women's health and wound care markets; Pharmaceutical, which is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension; and Medical Devices, which includes products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 68,288 68,288 115,451 522,170
Total Sell Value $10,723,734 $10,723,734 $18,652,688 $88,845,171
Total People Sold 2 2 5 10
Total Sell Transactions 2 2 5 24
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 606
  Page 3 of 25  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Taubert Jennifer L EVP, WW Chair, Pharmaceuticals   •       •      –    2024-02-09 4 S $156.27 $9,281,969 D/D (59,397) 141,416 7%     
   Taubert Jennifer L EVP, WW Chair, Pharmaceuticals   •       •      –    2024-02-09 4 OE $90.44 $5,371,865 D/D 59,397 200,813     -
   Wolk Joseph J Exec VP, CFO   •       •      –    2024-02-08 4 D $156.33 $163,678 D/D (1,047) 52,864     -
   Wolk Joseph J Exec VP, CFO   •       •      –    2024-02-08 4 OE $0.00 $0 D/D 3,686 53,911     -
   Duato Joaquin CEO and Chairman of the Board   •       •      –    2024-02-08 4 D $156.33 $354,713 D/D (2,269) 308,314     -
   Duato Joaquin CEO and Chairman of the Board   •       •      –    2024-02-08 4 OE $0.00 $0 D/D 5,225 310,583     -
   Swanson James D. See Remarks   •       •      –    2024-02-08 4 D $156.33 $86,607 D/D (554) 10,557     -
   Swanson James D. See Remarks   •       •      –    2024-02-08 4 OE $0.00 $0 D/D 1,868 11,111     -
   Forminard Elizabeth Executive VP, General Counsel   •       •      –    2024-02-08 4 D $156.33 $56,748 D/D (363) 6,100     -
   Forminard Elizabeth Executive VP, General Counsel   •       •      –    2024-02-08 4 OE $0.00 $0 D/D 979 6,463     -
   Wengel Kathryn E EVP, Chief TO and Risk Officer   •       •      –    2024-02-08 4 D $156.33 $157,737 D/D (1,009) 66,896     -
   Wengel Kathryn E EVP, Chief TO and Risk Officer   •       •      –    2024-02-08 4 OE $0.00 $0 D/D 1,971 67,905     -
   Fasolo Peter Exec VP, Chief HR Officer   •       •      –    2024-02-08 4 D $156.33 $122,094 D/D (781) 103,684     -
   Fasolo Peter Exec VP, Chief HR Officer   •       •      –    2024-02-08 4 OE $0.00 $0 D/D 2,135 104,465     -
   Broadhurst Vanessa EVP, Global Corp Affairs   •       •      –    2024-02-08 4 D $156.33 $109,900 D/D (703) 20,380     -
   Broadhurst Vanessa EVP, Global Corp Affairs   •       •      –    2024-02-08 4 OE $0.00 $0 D/D 1,880 21,083     -
   Hait William See Remarks   •       •      –    2024-02-08 4 D $156.33 $173,995 D/D (1,113) 33,384     -
   Hait William See Remarks   •       •      –    2024-02-08 4 OE $0.00 $0 D/D 3,059 34,497     -
   Schmid Timothy EVP, WW Chair, MedTech   •       •      –    2024-02-08 4 D $156.33 $156,486 D/D (1,001) 9,942     -
   Schmid Timothy EVP, WW Chair, MedTech   •       •      –    2024-02-08 4 OE $0.00 $0 D/D 1,964 10,943     -
   Decker Robert J VP Corporate Controller   •       •      –    2024-02-08 4 D $156.33 $33,611 D/D (215) 17,357     -
   Decker Robert J VP Corporate Controller   •       •      –    2024-02-08 4 OE $0.00 $0 D/D 655 17,572     -
   Taubert Jennifer L EVP, WW Chair, Pharmaceuticals   •       •      –    2024-02-08 4 D $156.33 $299,059 D/D (1,913) 141,416     -
   Taubert Jennifer L EVP, WW Chair, Pharmaceuticals   •       •      –    2024-02-08 4 OE $0.00 $0 D/D 3,739 143,329     -
   Schmid Timothy EVP, WW Chair, MedTechOfficer   •       –      –    2023-10-23 3 IO $0.00 $0 D/D 0 8,979 6%     
  606 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 3 of 25
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us